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Background: Changes in androgen dynamics within adipose tissue have been proposed as modulators of body fat
accumulation. In this context, AKR1C2 likely plays a significant role by inactivating 5α-dihydrotestosterone.
Aim: To characterize AKR1C2 expression patterns across adipose depots and cell populations and to provide
insight into the link with body fat distribution and genetic regulation.
Methods: We used RNA sequencing data from severely obese patients to assess patterns of AKR1C2 and AKR1C3
expression in abdominal adipose tissue depots and cell fractions. We additionally used data from 856 women to
assess AKR1C2 heritability and to link its expression in adipose tissue with body fat distribution. Further, we used
public resources to study AKR1C2 genetic regulation as well as reference epigenome data for regulatory element
profiling and functional interpretation of genetic data.
Results: We found that mature adipocytes and adipocyte-committed adipocyte progenitor cells (APCs) had
enriched expression of AKR1C2. We found adipose tissue AKR1C2 and AKR1C3 expression to be significantly and
positively associated with percentage trunk fat mass in women. We identified strong genetic regulation of
AKR1C2 by rs28571848 and rs34477787 located on the binding sites of two nuclear transcription factors, namely
retinoid acid-related orphan receptor alpha and the glucocorticoid receptor.
Conclusion: We confirm the link between AKR1C2, adipogenic differentiation and adipose tissue distribution. We
provide insight into genetic regulation of AKR1C2 by identifying regulatory variants mapping to binding sites for
the glucocorticoid receptor and retinoid acid-related orphan receptor alpha which may in part mediate the effect
of AKR1C2 expression on body fat distribution.

1. Introduction
Obesity is associated with numerous cardiometabolic complications
including the metabolic syndrome (Shungin et al., 2015), type 2 diabetes
(T2D) and cardiovascular diseases (CVD). Despite this widely
acknowledged association, not all individuals with a body mass index
(BMI) above 30 kg/m2 develop metabolic impairments (Tchernof and
Despres, 2013). In this framework, body fat distribution is an established
factor strongly contributing to a deleterious cardiometabolic profile

(Tchernof and Despres, 2013). Indeed, increased abdominal obesity,
linked to ectopic fat and in particular excess visceral adipose tissue
(VAT), positively correlates with insulin resistance and atherogenic
dyslipidemia (Tchernof and Despres, 2013). More so than increases in
subcutaneous adipose tissue (SAT) mass, VAT expansion is associated
with adipose tissue dysfunction, a set of histologic and cellular charac
teristics including, among others, adipocyte hypertrophy (Michaud
et al., 2016; Laforest et al., 2015), impaired adipogenesis (Lessard et al.,
2014; Gustafson et al., 2019), increased macrophage infiltration
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(Michaud et al., 2012), fibrosis (Esteve et al., 2019; Michaud et al.,
2005), insulin resistance (Michaud et al., 2016; Laforest et al., 2015),
decreased lipid uptake (Normand-Lauziere et al., 2010) and impaired
triglyceride synthesis (Cote et al., 2014). The protective role of SAT has
been reported in a number of studies (Lessard et al., 2014; Esteve et al.,
2019). The underlying hypothesis is that SAT may be more prone to
adipogenesis than VAT, thereby providing better expansion capacity and
lipid handling in the post-prandial phase (Neeland et al., 2019). The
strong association between excess VAT accumulation, adipose tissue
dysfunction and systemic metabolic imbalance (Neeland et al., 2019)
additionally stresses the importance of body fat distribution.
Body fat distribution is a trait showing strong heritability, in some
cases as high as 50% (Tchernof and Despres, 2013). Regarding possible
DNA variants that may be inherited, single nucleotide polymorphisms
(SNPs) are certainly one of the most frequent point-modifications
involved. Since the advent of high-throughput technologies allowing
whole-genome analysis, a number of genome-wide association studies
looking into SNPs related to body fat distribution have been published
(Shungin et al., 2015; Rask-Andersen et al., 2019; Fehlert et al., 2017;
Chu et al., 2017; Glastonbury et al., 2019; Benton et al., 2013; Randall
et al., 2013). Some found a considerable number of SNPs that were
related to markers of adipose tissue function, including lipid accumu
lation (Shungin et al., 2015; Benton et al., 2013), adipocyte differenti
ation (Chu et al., 2017) or glycemic control (Shungin et al., 2015). Most
of these studies reported sex-specific effects (Shungin et al., 2015; Ras
k-Andersen et al., 2019; Fehlert et al., 2017; Chu et al., 2017; Randall
et al., 2013), suggesting a possible involvement of sex hormones.
Consistent with these findings, androgens such as testosterone (T) and
5α-dihydrotestosterone (5α-DHT) have been identified as modulators of
body fat distribution in both men and women (Tchernof et al., 2018). A
comprehensive review of available literature showed that women with
high serum T display android obesity whereas low T is related to more
abdominal fat accumulation in men (Tchernof et al., 2018). From the
molecular point of view, aldo-ketoreductases 1C such as AKR1C2 and
AKR1C3 may be of importance for local androgen metabolism because
they can locally modulate 5α-DHT and T levels (Tchernof et al., 2015).
AKR1C3 possesses a significant 17β-hydroxysteroid dehydrogenase
(17β-HSD) activity (Zhang et al., 2000), for example reducing the pre
cursor androstenedione to T (Tchernof et al., 2015). AKR1C2 has
3α-HSD activity and is responsible for the specific inactivation of the
potent androgen 5α-DHT into 5α-androstane-3α,17β-diol (Zhang et al.,
2000; Blouin et al., 2003), a much weaker ligand of the androgen re
ceptor (AR). Specific downregulation of AKR1C2 in preadipocytes was
found to potentiate the inhibitory effect of 5α-DHT on adipogenic dif
ferentiation (Veilleux et al., 2012). Thus, the adipose-specific expression
of enzymes involved in androgen metabolism are linked with obesity
phenotypes and may be further involved in determining the patterns of
body fat distribution in humans.
In the present study, we aimed at characterizing the genetic variants
of AKR1C2 and to further relate its expression in adipose tissue cell
populations and body fat distribution. We hypothesized that increased
AKR1C2 expression is associated with abdominal obesity and that
analysis of genetic variants in key regulatory elements suggests putative
mechanisms related to possible hormonal control of AKR1C2 expression.

tissue (SAT) samples were obtained under the umbilicus (8 mm deep),
fat was weighted and immediately frozen in liquid nitrogen. The
detailed methodology of SAT processing has already been published
(Grundberg et al., 2012). Briefly, tissues were homogenized and RNA
extracted using TRIzol Reagent (Invitrogen). RNA expression, in repli
cates, was measured by Illumina Human HT-12 V3 BeadChips (Illu
mina). Illumina probe annotation was manually analyzed using NCBI
Build 36 genome and only probes with no mismatches and already
identified on Ensembl or RefSeq were kept for analysis. In addition, for
the purposes of the current study, the probes were linked to transcript
variants and DNA locations using ensembl GrCh38 Biomart (http
://uswest.ensembl.org/biomart).
Expression-phenotype associations were performed as described
previously (Small et al., 2011) using a linear mixed-effects model,
implemented with the lme4 R package. The model was adjusted for both
fixed effects (age, batch) and random effects (family relationship and
zygosity).
As described previously (Grundberg et al., 2012), by taking advan
tage of the twin design it is possible to estimate the genetic and envi
ronmental contribution of gene expression heritability. Briefly, the
classical ACE model was applied, which allows the segregation of ge
netic expression variance into Additive genetic (A), Common environ
ment (C) and unique Environment (E) among mono- and dizygotic
twins.
2.2. Single-cell sequencing cohort
We used recently published data on stroma-vascular fraction (SVF)
single-cell RNA sequencing to examine AKR1C2 expression in various
cell types of adipose tissue (Vijay et al., 2020). 14 patients (10 women
and 4 men) awaiting for bariatric surgery were recruited through the
Biobank of the Quebec Heart and Lung Institute (IUCPQ-Université
Laval). Of these, 5 were diagnosed with T2D (2 men and 3 women).
However, due to the small sample size, analyses based on T2D diagnosis
were not performed. Adipose tissues from the greater omentum (VAT)
and abdominal subcutaneous adipose compartment (SAT) was taken at
the time of the surgery. This study was approved by the institutional
ethics committee and signed consent was obtained from all participants.
The complete methodology used can be found in (Vijay et al., 2020).
Following isolation of the SVF, cells were thawed, diluted in DMEM/F12
(10% fetal bovine serum and 1% penicillin-streptomycin) and cen
trifugated. The pellet was then resuspended in supplemented
DMEM/F12 and 12,000 cells per patient were loaded onto the Chro
mium Single Cell A Chip (10x Genomics). Cell capture, cDNA amplifi
cation and library preparation were performed using Chromium Single
Cell 3’ Library and Gel Bead Kit v2 (10x Genomics). Following the
evaluation of both library size and concentration, samples were
sequenced using Illumina HiSeq (Vijay et al., 2020). For the primary
analysis, we used Cell Ranger v.2.1.0 software from 10XGenomics with
GRCh38 as reference. The R package Seurat (Butler et al., 2018) was
used for secondary analysis such as filtering and dimensionality
reduction.
The SAT progenitor cell population was divided into 5 clusters, ac
cording to gene expression signature. SAT progenitor population 1 (SP1)
and SP3 expressed typical adipocyte progenitor cell (APC) markers such
as MGP, ADOP, CXCL14. In the original study (Vijay et al., 2020), the
two populations were considered as separate because only SP1 abun
dance positively correlated with plasma glucose levels and was more
prevalent in patients with T2D. SP2 was associated to adipogenic
commitment (APOE, FABP4, CEBPB and CD36 expression). On the other
hand, SP4 displayed a fibroblast-like signature (COL1A1, COL6A3 and
COL6A1) while SP5 showed inflammatory gene expression and related
to hematopoietic stem cells progenitors (CCL5, IL7R, IL32 expression)
(Vijay et al., 2020). Differential expression between clusters was eval
uated by the Wilconxon rank sum test in Seurat.

2. Methods
2.1. MuTHER cohort
We used data generated from the Multiple Tissue Human Expression
Resource (MuTHER) study that includes 856 European descent females
taking part in the TwinsUK Adult twin registry (Grundberg et al., 2012).
The study received ethical approval and written informed consent was
signed from participants before sample collection. Trunk fat mass was
measured by dual-energy X-ray absorptiometry (DXA) according to the
manufacturer protocol (Glastonbury et al., 2016). Subcutaneous adipose
2
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2.3. Adipose tissue RNA-sequencing cohort

Consortium atlas, 2020). Data mining was used on open-source data to
isolate the information on AKR1C2 and AKR1C3 expression in human
adipose tissues.

We included SAT and VAT samples from 43 individuals with severe
obesity (BMI ≥35.5 kg/m2, age 29–65 years) awaiting bariatric surgery
and recruited through the Biobank of the Quebec Heart and Lung
Institute (IUCPQ-Université Laval). Whole adipose tissue was
collagenase-digested using a modified version of the Robdell method
within 30 min of collection. The isolated mature adipocytes, SVF and
whole adipose tissue samples were cryopreserved and stored in liquid
nitrogen. From the frozen samples, 0.5 to 3 millions cells were resus
pended in 500 μL TRIzol Reagent. RNA was extracted using the miR
Neasy Mini Kit (Qiagen) according to the manufacturer’s protocol. RNA
library preparations were carried out on 500 ng RNA with RNA integrity
number (RIN) > 7 using Illumina TruSeq Stranded Total RNA Sample
preparation kit. Final libraries were analyzed on a Bioanalyzer and
sequenced on the Illumina HiSeq 2500. The sequence reads were
100–125 bp in length and pair-ended.
After trimming for quality (phred33 ≥ 30) and length (n ≥ 32),
Illumina adapters were clipped off using Trimmomatic v.0.35 (Bolger
et al., 2014). Filtered reads were then aligned to the GRCh37 human
reference wing STAR v.2.5.3a (Dobin et al., 2013). Raw read gene counts
were obtained using htseq-count v.0.6.0 (Anders et al., 2015). Differ
ential gene expression analysis was done using DeSeq2 v.1.18 (Love
et al., 2014).
The same samples were used to assess chromatin state in human
mature adipocytes using transposase-accessible chromatin using
sequencing (ATAC-Seq) (Buenrostro et al., 2013).

2.7. Variants prioritization
We prioritized variants in high LD using scoring algorithms such as
RegulomeDB (Boyle et al., 2012; Dong and Boyle, 2019) and IW scoring
system (Wang et al., 2018). The first is an online database combining
data from the ENCODE project, manual annotations and algorithms to
predict the effect of a single-base mutation on chromatin accessibility
and TF binding (Boyle et al., 2012). Just like RegulomeDB, a number of
similar algorithms have been published and made publicly available. IW
scoring system pools together a number of published algorithms with
experimental chromatin data available on ENCODE and Ensembl. The
output gives an overall score helping the ranking of genetic variants. To
prioritize SNPs, we used IW score (K10), which combines data from
CADD score, DeepSEA, EIGEN, FATHMM, FunSeq2, GWAVA, ReMM,
ENCODE, Ensembl and FANTOM5 (Wang et al., 2018).
Scores were normalized in R, reversing Regulome and DeepSEA
scales and standardizing each score’s vertical height by setting mini
mum to zero and maximum to one. Each score was then centered using
its median.
3. Results
3.1. Characterization of AKR1C2 expression across adipose tissue types

2.4. Genome mapping

Tissue-specific AKR1C2 expression was gathered from the National
Center for Biotechnology Information (NCBI) database, which includes
summary statistics regarding tissue-specific expression of protein-coding
genes in humans (Fagerberg et al., 2014). We found AKR1C2 to have its
highest expression in adipose tissue with levels up to 84.8 reads per
kilobase (kb) of transcript, per million of reads (RPKM). Its expression in
adipose tissue was more than double that observed in the liver (Fig. 1a).
We then accessed the GTEx resource which contains genome-wide
expression data on 54 tissue types across 948 donors (The GTEx Con
sortium atlas, 2020). As expected, GTEx reported that among adipose
tissue types, SAT had the highest AKR1C2 expression, where
AKR1C2-202 (ENST00000421196.7) was the most abundant transcript
(Fig. 1b). Interestingly, we also noted that an alternative non-coding
AKR1C2 transcript is expressed in adipose tissue, although its expres
sion was significantly lower than the one observed for the coding tran
scripts. The AKR1C2 maps to the reverse strand of chromosome 10
(Chr10:5060223), close to AKR1C3. Indeed, as for genome version
GRCh37, the two genes were separated by only 17.3 kb. As shown in
Fig. 1c, as many as nine glucocorticoid responsive elements (GRE) were
found upstream of AKR1C2.

Data on AKR1C2 gene were retrieved from publicly available data
bases such as NCBI (tissue expression in humans) and the GenotypeTissue Expression (GTEx) resource (https://gtexportal.org/) (mRNA
variant expression by tissue).
2.5. Chromatin modifications
Variants in linkage disequilibrium (LD) with the sentinel SNP
rs28571848 were retrieved from LDlink (https://ldlink.nci.nih.gov/?
tab=home) using genome version GRCh37. Variants with R2 values >
0.8 were considered to be in high LD and were further analyzed. Chro
matin modification, accessibility and transcription factor (TF) binding
tracks were obtained by searching the ENCODE project database
(https://www.encodeproject.org/) for experiments associated with
mature or differentiated adipocytes (where possible) and mapped to
GRCh38 genome version. Data on chromatin modification such as the
mono- and trimethylations of lysin 4 on histone 3 (H3K4me1 and
H3K4me3) and the acetylation of lysin 9 on histone 3 (H3K9ac) were
downloaded from the project ROADMAP epigenomics. Glucocorticoidreceptor (GR) binding (coded by the NR3C1) and histone acetyl
transferase E1A-associated protein p300 (EP300) were retrieved from
Chip-seq analysis conducted in the A594 cell line stimulated with
dexamethasone for 8 and 7 h respectively. Finally, gene loci and variant
mapping were downloaded from NCBI RefSeq Gene and SNPdb. Data
were plotted with the help of Integrative genomics viewer (IGV) (Rob
inson et al., 2017).

3.2. Patterns of AKR1C2 expression in adipose tissue-derived cell
populations
Firstly, we compared expression pattern in the two main cell frac
tions found in adipose tissue, including adipocytes and the SVF using
data from the adipose tissue RNA-sequencing cohort. We found that both
in SAT and VAT, adipocytes have a more abundant AKR1C2 expression
than SVF (log2 fold change: 4.60, adjusted p-value: 9.55 E− 125, log2 fold
change: 5.85, adjusted p-value: 1.25 E− 161 for SAT and VAT, respec
tively). A similar pattern, but less pronounced, was found for AKR1C3
expression across cell fractions (log2 fold change: 3.98, adjusted pvalue: 2.53 E− 85, log2fold change: 4.57, adjusted p-value: 1.1 E− 76 for
SAT and VAT, respectively).
Next, we used single-cell RNA sequencing data of the SVF derived
from 14 patients undergoing bariatric surgery (Vijay et al., 2020) and
compared AKR1C2 expression across APC populations in both SAT and
VAT. Similarly to what was hinted by GTEx, we confirmed that AKR1C2

2.6. Expression quantitative trait loci
The publicly available 8th version of the GTEx resource (http
s://gtexportal.org/), was used to collect data of SNP effects on
AKR1C2 and AKR1C3 expression in adipose tissue. GTEx is a wellknown resource providing a rich catalog of densely profiled tissue
samples including subcutaneous, visceral and mammary adipose tissues
(SAT, VAT and MAT) with precomputed association analysis of geno
types and expression to identify quantitative trait loci (eQTL) (The GTEx
3
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Fig. 1. AKR1C2 expression. AKR1C2 expression in human tissues (A), most common transcripts of AKR1C2 in adipose tissue (B, modified from GTEx), AKR1C2
locus on chromosome 10 (C, modified from IgV).

fold change: 0.05, adjusted p-value: 2.74 E−

was significantly more expressed in SAT than VAT (log fold change:
0.20, adjusted p-value: 3.74 E− 24, Fig. 2a). Given the higher expression
of AKR1C2 in SAT, we focused on SAT progenitor cells only. When
combining men and women together, we found AKR1C2 to be expressed
more abundantly in adipocyte-committed APCs expressing APOE,
FABP4 and CEBPB (labeled SP2 cells) compared to the other populations
such as SP1 and SP3 (expressing APCs markers), SP4 (associated with
extracellular matrix synthesis and fibrosis) or SP5 (representing he
matopoietic stem cell progenitors) (Fig. 2b and c). Indeed, SP2 expressed
significantly higher AKR1C2 compared to SP1,3 and 4 combined (log

05

).

3.3. Linking AKR1C2 expression to phenotype
Using the MuTHER adipose tissue resource, which combines SAT
gene expression in 856 deeply phenotyped women, we investigated the
association between AKR1C2 and trunk fat mass. We found AKR1C2
expression to be positively and significantly associated with percent
trunk fat mass, even after adjustment for BMI (Table 1).
We also found this association for AKR1C3 expression. Interestingly,
4
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Fig. 2. Characterization of AKR1C2 and
AKR1C3 expression in the stroma vascular
fraction of adipose tissue at the single-cell level.
AKR1C2 and AKR1C3 expression in subcutaneous
(SAT) and visceral (VAT), all cells combined.
Expression (mean ± SD): AKR1C2 SAT: 2.73 ± 0.48;
VAT: 2.67 ± 0.72; AKR1C3 SAT: 2.71 ± 0.52; VAT:
2.86 ± 0.60 (A); in subcutaneous clusters of the
stroma vascular fraction (B), SP1and SP3: adipocyte
progenitor cells (APCs), mean ± SD expression SP1:
AKR1C2 2.02 ± 0.69; AKR1C3 1.96 ± 0.76; SP3:
AKR1C2 1.46 ± 0.39; AKR1C3 2.26 ± 0.70), SP2:
adipocyte-committed APCs (mean AKR1C2 expres
sion 2.09 ± 0.85; mean AKR1C3 expression 2.1 ±
0.89), SP4: fibroblasts (mean AKR1C2 expression
2.5 ± 0.69; mean AKR1C3 expression 2.25 ± 0.70),
SP5: hematopoietic stem cell progenitors (mean
AKR1C2 expression 1.66 ± 0.4; mean AKR1C3
expression 1.70 ± 0.53); percent of cells expressing
and average expression of AKR1C2 and AKR1C3 in
the different subcutaneous clusters (C).

Table 1
Subcutaneous adipose tissue gene expression in the Multiple Tissue Human Expression Resource (MuTHER, part of TwinsUK). Associations with percentage
trunk fat mass or trunk fat mass adjusted for BMI and the expression of AKR1C2 and AKR1C3 in subcutaneous adipose tissue.
Probe ID
ILMN_2412336
ILMN_1713124

Location
chr10:5011031:5022080
chr10:5139765:5139814

Gene
AKR1C2
AKR1C3

Trunk fat mass (%)

Trunk fat mass (%), BMI adjusted

P-value (ANOVA)

Q value

Beta

p-value (chi square)

Q value

Beta

2.2 E–49
2.1 E–70

2.5 E–47
8.7 E–68

0.023
0.037

7.8 E–30
4.3 E–31

3.3 E–27
2.1 E–28

0.026
0.034

the probe having the strongest association with percent trunk fat mass in
women (BMI-adjusted p-value: 7.8 E− 30) was tracked to the AKR1C2202 transcript variant (ENST00000421196.7) which we described
above being the most prevalent transcript in adipose tissue (Fig. 1b).
However, we found an association for the AKR1C2 transcript variant
209 (ENST00000604507.5), although less significant (BMI-adjusted pvalue of 5.2 E− 05).

Table 2
Minor allele frequency in the 1000 genome and TwinsUK cohorts. The two
alleles found on the forward DNA strand (most frequent/rare) are listed, fol
lowed by the minor allele frequency (MAF) reported by 1000 genome (1000G)
and TwinsUK. Data were retrieved from RefSNP.

3.4. Genetic regulation of AKR1C2 expression
We sought to estimate the regulation of AKR1C2 expression and
again used the MuTHER cohort to assess the genetic and non-genetic
contribution to AKR1C2 expression variation in adipose tissue specif
ically. As we have shown before (Grundberg et al., 2012), MuTHER
includes dizygotic and monozygotic twins and allows for the estimation
of heritability (h2) of expression levels as well as shared and unique
environmental contributions. Results point to a heritability of AKR1C2
expression of approximately 40%, while the environment seems to
contribute to a larger extent in adipose tissue with an h2 of 0.56.
We then aimed to map the underlying common genetic effect of
AKR1C2 expression and used the GTEx database for genotypeexpression association. Our analyses identified rs28571848 with a
minor allele frequency smaller than 20% (Table 2) as the strongest

SNP

Allele

Minor allele frequency
(1000G)

Minor allele frequency
(TwinsUK)

rs28571848
rs12411321
rs34477787
rs1937907

C/T
T/C
C/A
G/A

15.3%
12.5%
12.4%
16.9%

18.6%
17.6%
17.7%
–

association with SAT expression level of AKR1C2 (p = 7.8E− 12). Inter
estingly, the same variant (rs28571848) was also the top associated SNP
with SAT AKR1C3 expression (p = 2.1E− 33).
However, rs28571848 was in strong linkage disequilibrium (LD)
with a number of other SNPs (Fig. 3a). Indeed, some SNPs having R2
values ≥ 0.8 were localized more than 20 kb from the AKR1C2 tran
scription start site. We found that all of the SNPs in LD with rs28571848
have the same direction of effect for both AKR1C2 and AKR1C3
expression, but the most pronounced effects are on AKR1C3 expression.
For both genes, these effects were consistently greater in SAT than in
VAT (Fig. 3b). We identified 4 SNPs with a less pronounced influence on
5
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Fig. 3. Identification of a possible causal single nucleotide polymorphism. Single nucleotide polymorphisms in linkage disequilibrium with rs28571848 (A),
effect on AKR1C2 and AKR1C3 gene expression in both subcutaneous and visceral adipose tissue of possible causal single nucleotide polymorphisms (B), chromatin
state obtained with ATACseq of mature adipocytes upstream AKR1C2 and localization of common genetic variants (C), epigenetic environment around rs28571848,
rs34477787, rs1937907, rs12411321 (D, modified from IgV), plot pooling the results obtained with Regulome, CADD score, DeepSEA, EIGEN, FATHMAN, FunSeq2,
RaMM and IWScore (K10) scoring algorithms (E).

AKR1C2 expression: rs12416161, rs1937907, rs12769178 and
rs11252885 (Fig. 3b). Using additional data on open chromatin state
gathered from our adipose tissue RNA-sequencing cohort (see method
section) using ATAC-seq on SAT-derived human mature adipocytes
(Fig. 3c), we found that rs34477787, rs28571848 and rs12411321
overlapped open chromatin in human mature adipocytes. On the other
hand, data from the Roadmap epigenomic project revealed that
rs11252894, rs193788, rs12769178, rs11252885 are found in hetero
chromatin or a quiescent state (data not shown).
In light of the data collected, we decided to focus our efforts on
rs28571848, rs34477787, rs12411321 and rs11252899. To better un
derstand the impact that these SNPs may have on adipose tissue gene
expression and their likelihood to affect chromatin state, we interro
gated the Regulome database (Regulome DB). We found that a number
of variants were in close proximity with many transcription factor
binding sequences, identified by either chromatin immunoprecipitation
(Baars et al., 2016), position weight matrixes (PWM) or motif. In
particular, we found that rs28571848 was within the retinoic
acid-related orphan receptor alpha (RORA) sequence, that rs12411321
was associated with the subunit 2A of polymerase II during dexameth
asone stimulation, and that rs11252899 was in the sequence recognized
by Oct-1 (data not shown). rs34477787 was found in the sequence
recognized by GR, while rs1937907 was located on a sequence that
co-immunoprecipitated with EP300 (Fig. 3c and d). In light of these
results, we decided to further investigate the chromatin state around the
four likely functional SNPs, being rs28571848, rs12411321,
rs34477787 and rs1937907. Overall, data collected from ENCODE show
that rs34477787, rs1937907 and rs28571848 may be located in an
accessible locus with open chromatin (Fig. 3d).
To better understand the impact of these SNPs, we pooled together
the results gathered using both Regulome DB and IW scoring system. As

illustrated in Fig. 3e, our results clearly identified rs34477787 as the
SNP that is more likely to affect both chromatin state and gene tran
scription. Indeed, among the 10 SNPs tested no other SNP consistently
performed as well as rs34477787 across the algorithms tested. Inter
estingly, although rs34477787 outperformed the other SNPs, according
to Regulome DB, rs28571848 is more likely to be a regulatory variant
(rank: 2b, 3a probability: 0.75, 0.78 for rs28571848 and rs34477787
respectively).
4. Discussion
Our aim was to relate AKR1C2 expression in adipose tissue to body
fat distribution and to characterize AKR1C2 upstream variants known to
increase its transcription. We found AKR1C2 to be strongly expressed in
adipose tissue, where the transcript variant 202 (ENST00000421196.7)
was the most expressed. Our analyses of adipose cell populations
confirmed the upregulation of AKR1C2 expression in mature adipocytes
of both SAT and VAT. We then investigated the stromal fraction of ad
ipose tissue and identified a specific cell population cluster upregulating
AKR1C2. Additional analyses on gene expression in these cells revealed
that this population belonged to the adipocyte committed APCs in SAT.
The increase of AKR1C2 expression as a function of adipogenic
commitment and more generally, preadipocyte differentiation, are
supported by the literature, where AKR1C2 has been found to be one of
the most expressed steroid-converting enzymes in mature adipocytes
(Veilleux et al., 2012). AKR1C2 plays an essential role in androgen
turnover in adipose tissue (Zhang et al., 2000). Indeed, by inactivating
5α-DHT during the early steps of adipogenesis, AKR1C2 may facilitate
lipid accumulation into the differentiating pre-adipocytes (Veilleux
et al., 2012).
Our results show a strong association between AKR1C2 as well as
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AKR1C3 expression and percent trunk fat mass in women, where the
most compelling evidence came from the association with AKR1C2
transcript variant 202. A number of studies indicated that the intraadipose expression of AKR1C2 and AKR1C3 expression in adipose tis
sue is positively associated with adiposity indices. In our previously
published works, we reported a significant positive association between
AKR1C2 expression as well as its enzymatic activity in adipose tissue and
visceral fat accumulation (Blouin et al., 2003). The same association was
found between adipocyte cell size and AKR1C2 expression or activity in
adipose tissue. Similar results were found in a second sample of 45
participants, were AKR1C2 and AKR1C3 expression in adipose tissue
were positively correlated with the waist-hip ratio (Wake et al., 2007),
another marker of preferential android fat accumulation. Recently,
another group suggested a possible role of both steroid-converting en
zymes in the pathogenesis of human obesity. Irrespective of sex, in
BMI-discordant twins, intra-adipose expression of AKR1C2 and AKR1C3
were found to be higher in the heavier twin (Vihma et al., 2017, 2018).
As a consequence, serum concentration of 5α-DHT were found to differ,
with the heavier twin having the lower concentration (Vihma et al.,
2017, 2018). Interestingly, the difference in serum concentration be
tween the leaner and the heavier co-twin was inversely correlated with
their difference in both abdominal and subcutaneous fat accumulation
(Vihma et al., 2017, 2018). In addition, AKR1C3 has been recently
shown to have as preferred substrate androgen precursor 11- ketoan
drostenedione (11KA4) (Barnard et al., 2018). 11-hydroxy and
11-ketoandrogens have been shown to activate the androgen receptor to
a greater extent as opposed to classical androgens (Pretorius et al., 2016)
and to be associated to a number of pathological conditions such as the
polycystic ovary syndrome (O’Reilly et al., 2017; Turcu et al., 2020).
Hence our results may raise interesting questions on this developing
field of research. Our analysis further supports the role of AKR1C2 in
adipose tissue accumulation and body fat distribution and opens new
opportunities for research on 11-hydroxy and 11-ketoandrogens.
We additionally searched for possible genetic variation that might
increase AKR1C2 expression in adipose tissue and narrowed down to
two SNPs: rs28571848, rs34477787, while excluding rs1937907. Indeed
rs1937907, associated with the histone acetyltransferase EP300, is a
known coactivator of GR (Kino et al., 1999). The enzyme has been found
to bind simultaneously to the transcription machinery and to the GR
itself (Kino et al., 1999). This, added to the fact that rs34477787 and
rs1937907 were very closely located, led us to the assumption that
rs34477787 rather than rs1937907, was more likely to have a functional
effect. Regarding rs28571848, this SNP is linked to RORA, a nuclear
receptor that has been found to participate in pre-adipocyte commit
ment (Duez et al., 2009), white adipose tissue inflammation in mice
(Hams et al., 2020) and metabolic impairments in humans with the
metabolic syndrome (Vieira et al., 2014). On the other hand,
rs34477787 is found on the locus recognized by the GR. Glucocorticoids
are known to induce AKR1C2 expression in human pre-adipocytes
(Veilleux et al., 2012), and the degree of pre-adipocyte sensitivity to
induce androgen inactivation following glucocorticoid exposure is
positively associated with BMI in humans (Veilleux et al., 2012). The
identification of a SNP affecting AKR1C2 expression and located on a
sequence recognized by the GR highlights once more the tight connec
tion that exists between androgen inactivation and glucocorticoids.
Finally, our analyses revealed a strong hormonal component likely
governing AKR1C2 expression in adipose tissue. This may explain why
this enzyme is rarely identified as a strong contributor to body fat dis
tribution in GWAS studies (Shungin et al., 2015; Rask-Andersen et al.,
2019; Fehlert et al., 2017; Chu et al., 2017; Glastonbury et al., 2019;
Benton et al., 2013; Randall et al., 2013). Although reasons underlying
the less important heritability of AKR1C2 expression compared to
environmental regulation are only speculative at this time, we suggest
that the large environmental influences might be associated with the
local steroidogenic environment prevailing in adipose tissue in any
given situation. Indeed, in light of the known genetic control of AKR1C2

transcription by other steroids, it is plausible to hypothesize that the
load in both androgens and glucocorticoids in adipose tissue can affect
AKR1C2 transcription in humans.
5. Conclusion
In conclusion, our study confirms the link between AKR1C2, adipo
genic commitment and adipose tissue distribution. Moreover, we iden
tified a SNP liking AKR1C2 gene expression in adipose tissue to
glucocorticoid response in humans, consistent with the interplay be
tween glucocorticoids and 5α-DHT inactivation. Additional hormonemediated regulatory pathways controlling AKR1C2 transcription and
including the retinoic acid receptor, may be involved.
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Glastonbury, C.A., Viñuela, A., Buil, A., Halldorsson, G.H., Thorleifsson, G., Helgason, H.,
et al., 2016. Adiposity-dependent regulatory effects on multi-tissue transcriptomes.
Am. J. Hum. Genet. 99 (3), 567–579.
Glastonbury, C.A., Couto Alves, A., El-Sayed Moustafa, J.S., Small, K.S., 2019. Cell-type
heterogeneity in adipose tissue is associated with complex traits and reveals diseaserelevant cell-specific eQTLs. Am. J. Hum. Genet. 104 (6), 1013–1024.
Grundberg, E., Small, K.S., Hedman Å, K., Nica, A.C., Buil, A., Keildson, S., et al., 2012.
Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat. Genet.
44 (10), 1084–1089.
Gustafson, B., Nerstedt, A., Smith, U., 2019. Reduced subcutaneous adipogenesis in
human hypertrophic obesity is linked to senescent precursor cells. Nat. Commun. 10
(1), 2757.
Hams, E., Roberts, J., Bermingham, R., Hogan, A.E., O’Shea, D., O’Neill, L., et al., 2020.
Role for retinoic acid-related orphan receptor alpha (RORα) expressing macrophages
in diet-induced obesity. Front. Immunol. 11, 1966.
Kino, T., Nordeen, S.K., Chrousos, G.P., 1999. Conditional modulation of glucocorticoid
receptor activities by CREB-binding protein (CBP) and p300. J. Steroid Biochem.
Mol. Biol. 70 (1–3), 15–25.
Laforest, S., Labrecque, J., Michaud, A., Cianflone, K., Tchernof, A., 2015. Adipocyte size
as a determinant of metabolic disease and adipose tissue dysfunction. Crit. Rev. Clin.
Lab Sci. 52 (6), 301–313.
Lessard, J., Laforest, S., Pelletier, M., Leboeuf, M., Blackburn, L., Tchernof, A., 2014. Low
abdominal subcutaneous preadipocyte adipogenesis is associated with visceral
obesity, visceral adipocyte hypertrophy, and a dysmetabolic state. Adipocyte 3 (3),
197–205.
Love, M.I., Huber, W., Anders, S., 2014. Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2. Genome Biol. 15 (12), 550.
Michaud, A., Tordjman, J., Pelletier, M., Liu, Y., Laforest, S., Noel, S., et al., 2005.
Relevance of omental pericellular adipose tissue collagen in the pathophysiology of
human abdominal obesity and related cardiometabolic risk. Int. J. Obes. 40 (12),
1823–1831, 2016.
Michaud, A., Drolet, R., Noel, S., Paris, G., Tchernof, A., 2012. Visceral fat accumulation
is an indicator of adipose tissue macrophage infiltration in women. Metab., Clin.
Exp. 61 (5), 689–698.
Michaud, A., Laforest, S., Pelletier, M., Nadeau, M., Simard, S., Daris, M., et al., 2016.
Abdominal adipocyte populations in women with visceral obesity. Eur. J.
Endocrinol. 174 (2), 227–239.

Neeland, I.J., Ross, R., Després, J.-P., Matsuzawa, Y., Yamashita, S., Shai, I., et al., 2019.
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position
statement. The Lancet Diabetes & Endocrinology 7 (9), 715–725.
Normand-Lauziere, F., Frisch, F., Labbe, S.M., Bherer, P., Gagnon, R., Cunnane, S.C.,
et al., 2010. Increased postprandial nonesterified fatty acid appearance and
oxidation in type 2 diabetes is not fully established in offspring of diabetic subjects.
PloS One 5 (6), e10956.
O’Reilly, M.W., Kempegowda, P., Jenkinson, C., Taylor, A.E., Quanson, J.L., Storbeck, K.
H., et al., 2017. 11-Oxygenated C19 steroids are the predominant androgens in
polycystic ovary syndrome. J. Clin. Endocrinol. Metabol. 102 (3), 840–848.
Pretorius, E., Africander, D.J., Vlok, M., Perkins, M.S., Quanson, J., Storbeck, K.H., 2016.
11-Ketotestosterone and 11-ketodihydrotestosterone in castration resistant prostate
cancer: potent androgens which can No longer Be ignored. PloS One 11 (7),
e0159867.
Randall, J.C., Winkler, T.W., Kutalik, Z., Berndt, S.I., Jackson, A.U., Monda, K.L., et al.,
2013. Sex-stratified genome-wide association studies including 270,000 individuals
show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet. 9 (6),
e1003500.
Rask-Andersen, M., Karlsson, T., Ek, W.E., Johansson, A., 2019. Genome-wide
association study of body fat distribution identifies adiposity loci and sex-specific
genetic effects. Nat. Commun. 10 (1), 339.
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